Efficacy and safety profile of cefditoren, a new investigational cephalosporin

被引：0
|
作者：
Hom, R
Kidd, S
Hunt, B
Young, L
机构：
[1] Kuzell Inst Arhritis & Infect Dis, San Francisco, CA USA
[2] TAP Holdings Inc, Lake Forest, IL USA
来源：
CLINICAL INFECTIOUS DISEASES | 2000年 / 31卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
70
引用
收藏
页码：225 / 225
页数：1
相关论文
共 50 条
  • [41] Extended-release paliperidone: Efficacy, safety and tolerability profile of a new atypical antipsychotic
    Owen, Richard T.
    DRUGS OF TODAY, 2007, 43 (04) : 249 - 258
  • [42] ANTIBACTERIAL ACTIVITY OF THE INVESTIGATIONAL ORAL AND PARENTERAL CEPHALOSPORIN BK-218
    JOHNSON, DM
    JONES, RN
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1992, 11 (02) : 181 - 188
  • [43] INvestigational Vertebroplasty Efficacy and Safety Trial (INVEST): a randomized controlled trial of percutaneous vertebroplasty
    Gray, Leigh A.
    Jarvik, Jeffrey G.
    Heagerty, Patrick J.
    Hollingworth, William
    Stout, Lydia
    Comstock, Bryan A.
    Turner, Judith A.
    Kallmes, David F.
    BMC MUSCULOSKELETAL DISORDERS, 2007, 8 (1)
  • [44] COMMENTARY CONCERNING DEMONSTRATION OF SAFETY AND EFFICACY OF INVESTIGATIONAL ANTICANCER AGENTS IN CLINICAL-TRIALS
    OSHAUGHNESSY, JA
    WITTES, RE
    BURKE, G
    FRIEDMAN, MA
    JOHNSON, JR
    NIEDERHUBER, JE
    ROTHENBERG, ML
    WOODCOCK, J
    CHABNER, BA
    TEMPLE, R
    JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (12) : 2225 - 2232
  • [45] SAFETY, PHARMACOKINETICS AND EARLY SIGNALS FOR EFFICACY WITH ITI-007, A NOVEL INVESTIGATIONAL NEW DRUG FOR THE TREATMENT OF SCHIZOPHRENIA AND RELATED DISORDERS
    Vanover, Kimberly E.
    Davis, R. E.
    Ereshefsky, L.
    Gertsik, L.
    Ettekal, A. E.
    Mates, S.
    SCHIZOPHRENIA BULLETIN, 2011, 37 : 325 - 325
  • [46] INvestigational Vertebroplasty Efficacy and Safety Trial (INVEST): a randomized controlled trial of percutaneous vertebroplasty
    Leigh A Gray
    Jeffrey G Jarvik
    Patrick J Heagerty
    William Hollingworth
    Lydia Stout
    Bryan A Comstock
    Judith A Turner
    David F Kallmes
    BMC Musculoskeletal Disorders, 8
  • [47] How Aggregate Safety Assessment Planning Supports Investigational New Drug Safety Reporting Decisions
    Hendrickson, Barbara A.
    McShea, Cynthia
    Ball, Greg
    Talbot, Susan
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2024, 58 (04) : 579 - 590
  • [48] Safety profile of cefditoren. A pooled analysis of data from clinical trials in community-acquired respiratory tract infections
    Granizo, J. J.
    Aguilar, L.
    Gimenez, M. J.
    Coronel, P.
    Gimeno, M.
    Prieto, J.
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2009, 22 (02) : 57 - 61
  • [49] Efficacy and safety of new adjuvants
    Aucouturier, J
    Ganne, V
    Laval, A
    TROPICAL VETERINARY DISEASES: CONTROL AND PREVENTION IN THE CONTEXT OF THE NEW WORLD ORDER, 2000, 916 : 600 - 604
  • [50] Efficacy and Safety of New Anticoagulants
    Hacke, Werner
    CEREBROVASCULAR DISEASES, 2012, 34 : 8 - 8
12345